Article
Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast.
Breast cancer research : BCR - 16 Jun 2015
Pang Jia-Min B, Gorringe Kylie L, Wong Stephen Q, Dobrovic Alexander, Campbell Ian G, Fox Stephen B
Abstract excerpt
Ductal carcinoma in situ is a biologically diverse entity. Whereas some lesions are cured by local surgical excision, others recur as in situ disease or progress to invasive carcinoma with subsequent potential for metastatic spread. Reliable prognostic biomarkers are therefore desirable for appropriate clinical management but remain elusive. In common with invasive breast cancer, ductal carcinoma in situ exhibits...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
